549 related articles for article (PubMed ID: 10027844)
1. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
2. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.
Ferrari P; Torielli L; Ferrandi M; Padoani G; Duzzi L; Florio M; Conti F; Melloni P; Vesci L; Corsico N; Bianchi G
J Pharmacol Exp Ther; 1998 Apr; 285(1):83-94. PubMed ID: 9535997
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
4. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'.
Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G
Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814
[TBL] [Abstract][Full Text] [Related]
5. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G
Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940
[TBL] [Abstract][Full Text] [Related]
6. PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats.
Ferrandi M; Barassi P; Minotti E; Duzzi L; Molinari I; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 2002 Dec; 40(6):881-9. PubMed ID: 12451321
[TBL] [Abstract][Full Text] [Related]
7. Ouabain antagonists as antihypertensive agents.
Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P
Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive compounds that modulate the Na-K pump.
Ferrari P; Ferrandi M; Torielli L; Barassi P; Tripodi G; Minotti E; Molinari I; Melloni P; Bianchi G
Ann N Y Acad Sci; 2003 Apr; 986():694-701. PubMed ID: 12763920
[TBL] [Abstract][Full Text] [Related]
9. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium.
Efendiev R; Krmar RT; Ogimoto G; Zwiller J; Tripodi G; Katz AI; Bianchi G; Pedemonte CH; Bertorello AM
Circ Res; 2004 Nov; 95(11):1100-8. PubMed ID: 15528469
[TBL] [Abstract][Full Text] [Related]
10. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
Ferrari P
Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196
[TBL] [Abstract][Full Text] [Related]
11. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin.
Stenström K; Takemori H; Bianchi G; Katz AI; Bertorello AM
J Hypertens; 2009 Dec; 27(12):2452-7. PubMed ID: 19657284
[TBL] [Abstract][Full Text] [Related]
12. alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption.
Torielli L; Tivodar S; Montella RC; Iacone R; Padoani G; Tarsini P; Russo O; Sarnataro D; Strazzullo P; Ferrari P; Bianchi G; Zurzolo C
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F478-87. PubMed ID: 18524856
[TBL] [Abstract][Full Text] [Related]
13. Genetic aspects of ion transport systems in hypertension.
Bianchi G; Ferrari P; Cusi D; Tripodi G; Barber B
J Hypertens Suppl; 1990 Dec; 8(7):S213-8. PubMed ID: 1710265
[TBL] [Abstract][Full Text] [Related]
14. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
[TBL] [Abstract][Full Text] [Related]
15. Renal Na,K-ATPase in genetic hypertension.
Ferrandi M; Tripodi G; Salardi S; Florio M; Modica R; Barassi P; Parenti P; Shainskaya A; Karlish S; Bianchi G; Ferrari P
Hypertension; 1996 Dec; 28(6):1018-25. PubMed ID: 8952591
[TBL] [Abstract][Full Text] [Related]
16. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin.
Manunta P; Ferrandi M; Messaggio E; Ferrari P
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):61-6. PubMed ID: 16529550
[TBL] [Abstract][Full Text] [Related]
17. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.
Ferrari P; Ferrandi M; Valentini G; Bianchi G
Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R529-35. PubMed ID: 16467500
[TBL] [Abstract][Full Text] [Related]
18. Replacement of (alpha)1-Na-K-ATPase of Dahl rats by Milan rats lowers blood pressure but does not affect its activity.
Orlov SN; Dutil J; Hamet P; Deng AY
Physiol Genomics; 2001 Dec; 7(2):171-7. PubMed ID: 11773603
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension.
Ferrandi M; Salardi S; Tripodi G; Barassi P; Rivera R; Manunta P; Goldshleger R; Ferrari P; Bianchi G; Karlish SJ
Am J Physiol; 1999 Oct; 277(4):H1338-49. PubMed ID: 10516168
[TBL] [Abstract][Full Text] [Related]
20. Increased heart microsomal Na(+) K(+)-transporting ATPase activity by tetrandrine in spontaneously hypertensive rats.
Chen NH; Wang YL; Ding JH
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):320-5. PubMed ID: 8249625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
